FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37281508> ?p ?o ?g. }

• Q37281508 description "article científic" @default.
• Q37281508 description "article scientifique" @default.
• Q37281508 description "articolo scientifico" @default.
• Q37281508 description "artigo científico" @default.
• Q37281508 description "artículu científicu espublizáu en 2013" @default.
• Q37281508 description "bilimsel makale" @default.
• Q37281508 description "scientific article published on 05 August 2013" @default.
• Q37281508 description "vedecký článok" @default.
• Q37281508 description "vetenskaplig artikel" @default.
• Q37281508 description "videnskabelig artikel" @default.
• Q37281508 description "vědecký článek" @default.
• Q37281508 description "wetenschappelijk artikel" @default.
• Q37281508 description "wissenschaftlicher Artikel" @default.
• Q37281508 description "наукова стаття, опублікована в серпні 2013" @default.
• Q37281508 description "научни чланак" @default.
• Q37281508 description "مقالة علمية نشرت في 05 أغسطس 2013" @default.
• Q37281508 name "Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo." @default.
• Q37281508 name "Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo." @default.
• Q37281508 name "Dual blockade of the PI3K/AKT/mTOR" @default.
• Q37281508 type Item @default.
• Q37281508 label "Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo." @default.
• Q37281508 label "Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo." @default.
• Q37281508 label "Dual blockade of the PI3K/AKT/mTOR" @default.
• Q37281508 prefLabel "Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo." @default.
• Q37281508 prefLabel "Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo." @default.
• Q37281508 prefLabel "Dual blockade of the PI3K/AKT/mTOR" @default.
• Q37281508 P1433 Q37281508-399ADD75-8D6B-4A4C-89BE-70C046056A2A @default.
• Q37281508 P1476 Q37281508-59ADBDB0-E34A-43C1-AB86-C0A0700FDA6D @default.
• Q37281508 P2093 Q37281508-146E8701-5198-4D3E-B57B-A0C060E14D30 @default.
• Q37281508 P2093 Q37281508-200B1A9B-89F3-4D17-AB85-413451766020 @default.
• Q37281508 P2093 Q37281508-3107015B-9045-4256-BCC5-B2E84101ADC4 @default.
• Q37281508 P2093 Q37281508-7D484016-B774-4FAF-BA1A-7E713EE00F8F @default.
• Q37281508 P2093 Q37281508-81FF93C6-82D7-484C-9392-C6EABB867532 @default.
• Q37281508 P2093 Q37281508-8BA7636F-6F2D-4AE9-960A-C1B17A800E0A @default.
• Q37281508 P2093 Q37281508-AABAEDFB-3908-4FC2-8874-2C3C25AB8811 @default.
• Q37281508 P2093 Q37281508-D535E460-6538-4488-B107-16D89AFF7972 @default.
• Q37281508 P2093 Q37281508-D886891B-9C02-4C96-A292-0918CD3C655F @default.
• Q37281508 P2093 Q37281508-EB331A1F-CE03-49F4-9E5F-0EB2FFDC6362 @default.
• Q37281508 P2093 Q37281508-F166BB4D-B2A1-4DA8-83A5-FFE5AE606CF4 @default.
• Q37281508 P2860 Q37281508-1257FCD0-1CFD-4E16-B5CE-1092B16DD187 @default.
• Q37281508 P2860 Q37281508-186D8AFF-0CEC-4BCC-AB96-692B65F650D9 @default.
• Q37281508 P2860 Q37281508-1E4CA543-DEDC-481A-AC69-6272E4044088 @default.
• Q37281508 P2860 Q37281508-2050CD56-A7C4-4013-9758-81EFBD9C0A96 @default.
• Q37281508 P2860 Q37281508-279F177E-7EC8-489E-AB33-374C7A1D7C6A @default.
• Q37281508 P2860 Q37281508-2FFD3892-620B-433A-A9E6-04BD71F28468 @default.
• Q37281508 P2860 Q37281508-31F67F13-886F-4366-8072-1F20D4B18857 @default.
• Q37281508 P2860 Q37281508-4BAB6038-CB58-4E93-AAF2-20304B847D7E @default.
• Q37281508 P2860 Q37281508-4EBDF220-B2AE-4FDE-94C5-9AB4C591709B @default.
• Q37281508 P2860 Q37281508-54BB30BA-3404-489F-B292-B7766A318624 @default.
• Q37281508 P2860 Q37281508-5777C298-1673-4E75-9338-103BCE5DB779 @default.
• Q37281508 P2860 Q37281508-57D6B20E-1E9D-49F4-A02A-09CAED469651 @default.
• Q37281508 P2860 Q37281508-5B93727F-1F5D-4D43-BEF9-E6A22E30EB33 @default.
• Q37281508 P2860 Q37281508-5ED5309A-AA2F-4099-B8C3-16ACDC67DDAF @default.
• Q37281508 P2860 Q37281508-6131F50B-DD54-4E9D-8918-66552D463BD5 @default.
• Q37281508 P2860 Q37281508-630B2FF5-75B4-4314-82B1-2F9B86DCEA00 @default.
• Q37281508 P2860 Q37281508-6AD24965-63F0-4CE9-99F7-46B3B816446F @default.
• Q37281508 P2860 Q37281508-7A7E759B-96B0-4444-BA34-16B2D871D530 @default.
• Q37281508 P2860 Q37281508-8198ED8D-6B4D-48DD-A300-9FECCA43C7E8 @default.
• Q37281508 P2860 Q37281508-A1C0EDCC-E0FD-44FD-AC5F-E32D5A9985A1 @default.
• Q37281508 P2860 Q37281508-A1D50E9C-A944-460C-A2C0-7CD5784EA8F1 @default.
• Q37281508 P2860 Q37281508-A7DA1C2E-495C-4D7F-8C8E-0E46F79451CC @default.
• Q37281508 P2860 Q37281508-A91A3F8A-1FDD-40B2-9B82-12CD2332CBC0 @default.
• Q37281508 P2860 Q37281508-B0AD59AF-691F-4C9F-AC2B-258C7481145A @default.
• Q37281508 P2860 Q37281508-C356C643-A8EB-4995-80B9-5E0E8035DF95 @default.
• Q37281508 P2860 Q37281508-CB45D6BA-F905-4A8D-8AAD-D1795320C71C @default.
• Q37281508 P2860 Q37281508-CDF00090-F537-47D0-A026-C3AED30B7876 @default.
• Q37281508 P2860 Q37281508-F02A88F4-C976-44C9-82DB-E878E52C8D1A @default.
• Q37281508 P2860 Q37281508-F070C375-5967-4015-B066-F6C8595B1C12 @default.
• Q37281508 P2860 Q37281508-F09AEE1D-9E5A-4FF1-B2E3-35EF628C020A @default.
• Q37281508 P2860 Q37281508-F1148225-A89B-4E70-8A30-417019E1DE08 @default.
• Q37281508 P2860 Q37281508-F691CA1F-0DD5-4EEA-B51C-6DA81CF953DB @default.
• Q37281508 P2860 Q37281508-FB7ABE8D-CE79-4085-BE05-3B7E3E10967E @default.
• Q37281508 P2860 Q37281508-FD3B9EC7-0D25-4C99-BC75-26B5DA1413F8 @default.
• Q37281508 P304 Q37281508-D28C6FBE-CF40-4FF4-8964-2B7E393B7D32 @default.
• Q37281508 P31 Q37281508-1531E9E6-9BE8-417D-A19E-C900BFFD97DA @default.
• Q37281508 P356 Q37281508-3D4A66D7-5427-426B-981E-ED1EE8548CEF @default.
• Q37281508 P407 Q37281508-FC7A62BD-B950-4DE3-B97B-732C911D0505 @default.
• Q37281508 P433 Q37281508-BD6D5FD4-F209-4EFA-AA81-46C638AA6886 @default.
• Q37281508 P4510 Q37281508-CAB71155-4636-4A4D-970A-6BF22E164065 @default.
• Q37281508 P478 Q37281508-DA2D54FE-5884-425D-9967-7BB045A5C828 @default.
• Q37281508 P50 Q37281508-1DFC4357-1607-4F34-B180-8F93A028E908 @default.
• Q37281508 P50 Q37281508-39706E78-35F5-45AE-9105-FE667DC1E25D @default.
• Q37281508 P50 Q37281508-7C703496-8B4A-46A7-A421-AED25D3B68B4 @default.
• Q37281508 P50 Q37281508-9F526DCE-55A8-42DD-8CA8-DD6C7FC45785 @default.
• Q37281508 P577 Q37281508-4EEF0C5F-41FF-42EE-BCA6-54AE46AF41D9 @default.
• Q37281508 P698 Q37281508-F04C009D-2334-43F2-9EAB-16587D770063 @default.
• Q37281508 P921 Q37281508-6CE29B9E-A4BD-4834-AB51-689D94AF39E2 @default.
• Q37281508 P932 Q37281508-49E6E115-AF58-4BE1-AC2A-119E8F5FAB39 @default.
• Q37281508 P356 1078-0432.CCR-13-0850 @default.
• Q37281508 P698 23918606 @default.
• Q37281508 P1433 Q332253 @default.
• Q37281508 P1476 "Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo" @default.
• Q37281508 P2093 "Alexis De Haven Brandon" @default.
• Q37281508 P2093 "Andrew D Pearson" @default.
• Q37281508 P2093 "Jane Renshaw" @default.
• Q37281508 P2093 "Kathryn R Taylor" @default.
• Q37281508 P2093 "Louise D Johnson" @default.
• Q37281508 P2093 "Melanie Valenti" @default.
• Q37281508 P2093 "Ruth R Ruddle" @default.
• Q37281508 P2093 "Ryan Bishop" @default.

• next